RS
AXSM icon

Rakuten Securities’s Axsome Therapeutics AXSM Stock Holding History

Rakuten Securities’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47K Buy
6
+1
+20% +$217 ﹤0.01% 691
2026
Q1 		$845 Sell
5
-5
-50% -$864 ﹤0.01% 694
2025
Q4 		$1.83K Sell
10
-20
-67% -$2.79K ﹤0.01% 627
2025
Q3 		$3.64K Buy
30
+4
+15% +$451 ﹤0.01% 563
2025
Q2 		$2.71K Buy
26
+1
+4% +$106 ﹤0.01% 570
2025
Q1 		$2.92K Buy
+25
New +$2.85K ﹤0.01% 557

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Rakuten Securities's AXSM Position: Q2 2026 in Review

Rakuten Securities increased its Axsome Therapeutics (AXSM) stake by 20% in Q2 2026, buying an estimated $217 and bringing the position to 6 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Rakuten Securities first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.64K in Q3 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Rakuten Securities held 6 shares of Axsome Therapeutics worth $1.47K as of Q2 2026.
  • Rakuten Securities bought 1 Axsome Therapeutics share in Q2 2026, an estimated $217.
  • Axsome Therapeutics made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #691 holding.
  • Rakuten Securities first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Rakuten Securities's Axsome Therapeutics position peaked at $3.64K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.